COMPARISON OF GLUCOSE TOLERANCE, SERUM INSULIN, SERUM LIPIDS AND SKINFOLD THICKNESS BETWEEN 50- AND 60-YEAR-OLD MENWAERN U; BOBERG J.1979; UPSALA J. MED. SCI.; SWE; DA. 1979; VOL. 84; NO 3; PP. 203-214; BIBL. 38 REF.Article

METABOLIC ASPECTS OF PHYSICAL TRAINING IN MALE PATIENTS AFTER MYOCARDIAL INFARCTION = ASPECTS METABOLIQUES DE L'ENTRAINEMENT PHYSIQUE CHEZ DES MALADES HOMMES APRES INFARCTUS DU MYOCARDEBJERNULF A; BOBERG J.1974; UPSALA J. MED. SCI.; SWED.; DA. 1974; VOL. 79; NO 2; PP. 84-89; BIBL. 1P.1/2Article

Competition in Tanzanian woodfuel marketsBOBERG, J.Energy policy. 1993, Vol 21, Num 5, pp 474-490, issn 0301-4215Article

A METHOD OF DETERMINING LIPOPROTEIN-LIPASE ACTIVITY IN HUMAN ADIPOSE TISSUE.LITHELL H; BOBERG J.1977; SCAND. J. CLIN. LAB. INVEST.; NORWAY; DA. 1977; VOL. 37; NO 6; PP. 551-561; BIBL. 33 REF.Article

PURIFICATION OF SALT RESISTANCE LIPASE AND LIPOPROTEIN LIPASE FROM HUMAN POST-HEPARIN PLASMA.OESTLUND LINDQVIST AM; BOBERG J.1977; F.E.B.S. LETTERS; NETHERL.; DA. 1977; VOL. 83; NO 2; PP. 231-236; BIBL. 22 REF.Article

DETERMINATION OF LIPOPROTEIN-LIPASE ACTIVITY IN HUMAN SKELETAL MUSCLE TISSUE.LITHELL H; BOBERG J.1978; BIOCHIM. BIOPHYS. ACTA; PAYS-BAS; DA. 1978; VOL. 528; NO 1; PP. 58-68; BIBL. 24 REF.Article

LIPOPROTEIN LIPASE ACTIVITY IN ADIPOSE TISSUE OF SPONTANEOUSLY HYPERLIPIDEMIC RATSGUSTAFSSON K; KJESSLING H; BOBERG J et al.1981; ARTERY; ISSN 0098-6127; USA; DA. 1981; VOL. 9; NO 5; PP. 394-404; BIBL. 33 REF.Article

THE EARLY SERUM INSULIN RESPONSE TO INTRAVENOUS GLUCOSE IN PATIENTS WITH DECREASED GLUCOSE TOLERANCE AND IN SUBJECTS WITH A FAMILIAL HISTORY OF DIABETES MELLITUSBOBERG J; HEDSTRAND H; WIDE L et al.1976; SCAND. J. CLIN. LAB. INVEST.; NORWAY; DA. 1976; VOL. 36; NO 2; PP. 145-153; BIBL. 21 REF.Article

WILL SERUM LIPID LOWERING TREATMENT REDUCE THE INCIDENCE OF CORONARY HEART DISEASE.VESSBY B; LITHELL H; BOBERG J et al.1981; ARTERY; ISSN 0098-6127; USA; DA. 1981; VOL. 9; NO 5; PP. 372-381; BIBL. 15 REF.Article

REDUCTION OF LOW DENSITY AND HIGH DENSITY LIPOPROTEIN CHOLESTEROL BY FAT-MODIFIED DIETS. A SURVEY OF RECENT FINDINGSVESSBY B; LITHELL H; BOBERG J et al.1982; HUM. NUTR.: CLIN. NUTR.; ISSN 504149; GBR; DA. 1982; VOL. 36; NO 3; PP. 203-211; BIBL. 2 P.Article

LYOLYTIC ACTIVITIES IN POST-HEPARIN PLASMA IN MAN MESURED WITH DIFFERENT SUBSTRATE EMULSIONS.VESSBY B; BOBERG J; LITHELL H et al.1978; CLIN. SCI. MOLEC. MED.; GBR; DA. 1978; VOL. 54; NO 2; PP. 201-203; BIBL. 13 REF.Article

SUPPLEMENTATION WITH VITAMIN E IN HYPERLIPIDEMIC PATIENTS TREATED WITH DIET AND CLOFIBRATE. EFFECTS ON SERUM LIPOPROTEIN CONCENTRATIONS, PLASMA FATTY ACID COMPOSITION AND ADIPOSE TISSUE LIPOPROTEIN LIPASE ACTIVITY.VESSBY B; LITHELL H; BOBERG J et al.1977; AMER. J. CLIN. NUTRIT.; U.S.A.; DA. 1977; VOL. 30; NO 4; PP. 517-522; BIBL. 30 REF.Article

BINDING OF ANTI-IDIOTYPIC ANTIBODIES AGAINST HUMAN SERUM LOW DENSITY LIPOPROTEIN (LDL) TO SKIN FIBROBLASTSOSTLUND LINDOVIST AM; BOBERG J; LINDQVIST P et al.1980; ATHEROSCLEROSIS; ISSN 0021-9150; NLD; DA. 1980; VOL. 37; NO 1; PP. 123-128; BIBL. 15 REF.Article

Representative noise-free complete-link classification with application to protein structuresBOBERG, J; SALAKOSKI, T.Pattern recognition. 1997, Vol 30, Num 3, pp 467-482, issn 0031-3203Article

THE EFFECTS OF COLESTIPOL WHEN COMBINED WITH CLOFIBRATE IN THE TREATMENT OF SEVERE HYPERLIPIDEMIA: SHORT-TERM AND LONG-TERM STUDIESLITHELL H; VESSBY B; BOBERG J et al.1980; ATHEROSCLEROSIS; ISSN 0021-9150; NLD; DA. 1980; VOL. 37; NO 2; PP. 175-186; BIBL. 26 REF.Article

General formulation and evaluation of agglomerative clustering methods with metric and non-metric distancesBOBERG, J; SALAKOSKI, T.Pattern recognition. 1993, Vol 26, Num 9, pp 1395-1406, issn 0031-3203Article

LIPOPROTEIN-LIPASE ACTIVITY IN HUMAN SKELETAL MUSCLE AND ADIPOSE TISSUE IN THE FASTING AND THE FED STATES.LITHELL H; BOBERG J; HELLSING K et al.1978; ATHEROSCLEROSIS; NLD; DA. 1978; VOL. 30; NO 1; PP. 89-94; BIBL. 21 REF.Article

QUANTITATIVE DETERMINATION OF HEPATIC AND LIPOPROTEIN LIPASE ACTIVITIES FROM HUMAN POSTHEPARIN PLASMA.BOBERG J; AUGUSTIN J; BAGINSKY ML et al.1977; J. LIPID RES.; U.S.A.; DA. 1977; VOL. 18; NO 4; PP. 544-547; BIBL. 23 REF.Article

EFFECT OF PAS-C^R ON SERUM LIPOPROTEINS WHEN COMBINED WITH LIPID LOWERING DIET AND CLOFIBRATE.VESSBY B; LITHELL H; BOBERG J et al.1976; ARTERY; U.S.A.; DA. 1976; VOL. 2; NO 1; PP. 70-78; BIBL. 1 P. 1/2Article

CHANGES IN THE FATTY ACID COMPOSITION OF THE PLASMA LIPID ESTERS DURING LIPID-LOWERING TREATMENT WITH DIET, CLOFIBRATE AND NICERITROL: REDUCTION OF THE PROPORTION OF LINOLEATE BY CLOFIBRATE BUT NOT BY NICERITROLVESSBY B; LITHELL H; GUSTAFSSON IB et al.1980; ATHEROSCLEROSIS; NLD; DA. 1980; VOL. 35; NO 1; PP. 51-65; BIBL. 23 REF.Article

PRONOUNCED LIPOPROTEIN LIPID REDUCTION OBTAINED BY COMBINED LIPID-LOWERING TREATMENT IN PATIENTS WITH ATHEROSCLEROTIC DISEASEVESSBY B; LITHELL H; GUSTAFSSON IB et al.1979; ATHEROSCLEROSIS; NLD; DA. 1979; VOL. 33; NO 4; PP. 457-477; BIBL. 45 REF.Article

The other side of the block : the stutterer's spouseBOBERG, J. M; BOBERG, E.Journal of fluency disorders. 1990, Vol 15, Num 1, pp 61-75, issn 0094-730X, 15 p.Article

INCREASE OF THE LIPOPROTEIN-LIPASE ACTIVITY IN HUMAN SKELETAL MUSCLE DURING CLOFIBRATE ADMINISTRATION.LITHELL H; BOBERG J; HELLSING K et al.1978; EUROP. J. CLIN. INVEST.; GERM.; DA. 1978; VOL. 8; NO 2; PP. 67-74; BIBL. 58 REF.Article

PARA-AMINOSALICYLIC ACID AS A LIPID-LOWERING AGENT.VESSBY B; LITHELL H; BOBERG J et al.1978; CLIN. PHARMACOL. THERAPEUT.; USA; DA. 1978; VOL. 23; NO 6; PP. 651-657; BIBL. 28 REF.Article

LIPOPROTEIN-LIPASE ACTIVITY IN SUBCUTANEOUS, ADIPOSE TISSUE IN HEALTHY SUBJECTS. VARIATION OF ACTIVITY IN A POPULATION OF 60-YEAR-OLD MEN.LITHELL H; BOBERG J; HELLSING K et al.1978; UPPSALA J. MED. SCI.; SWED.; DA. 1978; VOL. 83; NO 1; PP. 45-52; BIBL. 30 REF.Article